4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-000005
CEO and CFO bought 3,200 shares at $11.12 ($35,584)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-12-30 | Purchase | +3,200 | $11.12 | $35,584 | 5,539,302 | D |
| Open-market purchases · 3,200 sh · avg $11.12 · $35,584 | |||||||
Loading xslF345X05/ownership.xml…